Sensus Healthcare, Inc. (SRTS)

Market Cap	56.98M
Revenue (ttm)	39.49M
Net Income (ttm)	1.80M
Shares Out	16.45M
EPS (ttm)	0.11
PE Ratio	31.41
Forward PE	9.43
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,189,640
Open	3.440
Previous Close	5.350
Day's Range	3.100 - 3.579
52-Week Range	3.100 - 9.329
Beta	1.35
Analysts	Strong Buy
Price Target	9.33 (+169.26%)
Earnings Date	Aug 7, 2025

About ML

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 V...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 3, 2016
• Employees: 54
• Stock Exchange: NASDAQ
• Ticker Symbol: SRTS
• Website: https://sensushealthcare.com

Financial Performance

In 2024, Sensus Healthcare's revenue was $41.81 million, an increase of 71.31% compared to the previous year's $24.41 million. Earnings were $6.65 million, an increase of 1270.52%.

Analyst Summary

According to 3 analysts, the average rating for SRTS stock is "Strong Buy." The 12-month stock price target is $9.33, which is an increase of 169.26% from the latest price.

Price Target

$9.33

(169.26% upside)

Analyst Consensus: Strong Buy